Example: Heart Attack

Search clinical trials for: Ropinirole

Total 78 results

NCT03806530

Recruiting

DIalysis Symptom COntrol-Restless Legs Syndrome Trial

Conditions: End Stage Renal Disease; Restless Legs Syndrome
NCT03708237

Suspended

Effectiveness of Ropinirole and Gabapentin for the Treatment of RLS in Patients on Maintenance HD

Conditions: Restless Legs Syndrome; End Stage Renal Disease
NCT03250117

Terminated

Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole

Conditions: Parkinson Disease
NCT03176966

Enrolling by invitation

Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis

Conditions: Muscle Cramp; Cirrhosis
NCT03038308

Active, not recruiting

Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole

Conditions: Hyperprolactinemia; Prolactinoma
NCT02994719

Active, not recruiting

Gait Analysis in Neurological Disease

Conditions: Parkinson's Disease; Parkinsonian Disorders; Atypical Parkinson Disease; Progressive Supranuclear Palsy; Multiple System Atrophy; Corticobasal Degeneration; Gait, Frontal; Huntington Disease
NCT02339064

Active, not recruiting

Infusion of Apomorphine: Long-term Safety Study

Conditions: Idiopathic Parkinson's Disease
NCT02138357

Withdrawn

Butrans for Treatment of Restless Legs Syndrome

Conditions: Restless Legs Syndrome
NCT01976871

Completed

Switching From Oral Dopamine Agonists to Rotigotine

Conditions: Restless Legs Syndrome; Ekbom Syndrome; Willis-Ekbom Disease
NCT01929317

Terminated

A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.

Conditions: Parkinson Disease
NCT01723904

Completed

A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease

Conditions: Advanced Parkinson's Disease
NCT01717235

Completed

Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fasting Conditions

Conditions: Pharmacokinetic Study
NCT01714856

Completed

Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fed Conditions

Conditions: Pharmacokinetic Study
NCT01712568

Completed

Two Way Cross Over BE Fasting Pilot Study of Ropinirole Hydrochloride CR 2mg Tablets

Conditions: Pharmacokinetic Study
NCT01711866

Completed

A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease

Conditions: Advanced Idiopathic Parkinson's Disease
NCT01628926

Completed

A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients

Conditions: Parkinson's Disease
NCT01627834

Completed

Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fasting Condition

Conditions: Healthy
NCT01627847

Completed

Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed Condition

Conditions: Healthy
NCT01536574

Completed

Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528

Conditions: Parkinson Disease
NCT01515774

Unknown status

Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID)

Conditions: Parkinson's Disease
NCT01494532

Completed

A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease

Conditions: Parkinson Disease
NCT01485172

Completed

A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease

Conditions: Parkinson Disease
NCT01435915

Completed

Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects

Conditions: Parkinson Disease
NCT01393457

Completed

Cognitive Remediation for Cocaine Dependence

Conditions: Cocaine Dependence
NCT01371682

Completed

A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda

Conditions: Parkinson Disease
NCT01327339

Completed

REQUIP RLS Post Marketing Surveillance

Conditions: Restless Legs Syndrome
NCT01154166

Completed

A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa

Conditions: Parkinson Disease
NCT01052831

Completed

Naltrexone for Impulse Control Disorders in Parkinson's Disease

Conditions: Impulse Control Disorder; Parkinson Disease
NCT01007864

Completed

Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists

Conditions: Idiopathic Parkinson's Disease
NCT00996944

Terminated

Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration)

Conditions: Restless Legs Syndrome
NCT00986245

Completed

Study to Compare the Effect of Ropinirole Prolonged Release Once-daily Versus Twice-daily

Conditions: Parkinson Disease
NCT00829504

Completed

Ropinirole 0.25 mg Tablets Under Fasting Conditions

Conditions: Healthy
NCT00830219

Completed

The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fed Conditions

Conditions: Healthy
NCT00823836

Completed

Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease

Conditions: Parkinson Disease
NCT00673088

Completed

A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted Conditions

Conditions: Parkinson's Disease; Restless Leg Syndrome
NCT00674310

Completed

A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions

Conditions: Parkinson's Disease; Restless Leg Syndrome
NCT00650104

Completed

Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164

Conditions: Parkinson Disease
NCT00639119

Unknown status

Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type

Conditions: Unverricht-Lundborg Syndrome
NCT00632736

Completed

An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease

Conditions: Parkinson Disease; Parkinson's Disease
NCT00605683

Completed

MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist

Conditions: Idiopathic Parkinson's Disease
NCT00593606

Completed

Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine

Conditions: Parkinson's Disease
NCT00530790

Completed

Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome

Conditions: Restless Legs Syndrome
NCT00485069

Completed

REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study

Conditions: Parkinson Disease; Parkinson's Disease
NCT00460148

Completed

Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole

Conditions: Parkinson Disease
NCT00434304

Completed

Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)

Conditions: Parkinson Disease
NCT00422994

Completed

A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole

Conditions: Restless Legs Syndrome
NCT00419692

Completed

Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food

Conditions: Restless Legs Syndrome
NCT00399477

Completed

A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

Conditions: Parkinson's Disease
NCT00381472

Completed

Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa

Conditions: Parkinson Disease
NCT00373542

Completed

12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome

Conditions: Restless Legs Syndrome (RLS); Restless Legs Syndrome

Search clinical trials for: Ropinirole

Recent CRA jobs

CRA (Level II)

Research Scientist

Commercial Analyst - Cambridge

(Senior) Optimization Specialist - PVG, EMEA or APAC

Prin Optimization Specialist - PVG, EMEA or APAC

Compliance Specialist - Home Based

Associate Data Manager - Labs

CRA - Client-dedicated, Vaccines - Finland

Associate Director/Director, Site Intelligence and Activation (oversight)

Statistical Analyst